Tenax Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -765.1% | -765.1% | -541.9% |
| FY2022 | 740.0% | 740.0% | 324.5% |
| FY2023 | -95.2% | -95.2% | -66.0% |
| FY2024 | -19.1% | -19.1% | -18.2% |
| FY2025 | -54.2% | -54.2% | -50.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -765.1% | -765.1% | -541.9% |
| FY2022 | 740.0% | 740.0% | 324.5% |
| FY2023 | -95.2% | -95.2% | -66.0% |
| FY2024 | -19.1% | -19.1% | -18.2% |
| FY2025 | -54.2% | -54.2% | -50.5% |